Actively Recruiting
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Led by Saint John's Cancer Institute · Updated on 2024-04-16
1000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.
CONDITIONS
Official Title
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical stage Tis, T1, or T2 (\u2264 3cm), N0, M0 (AJCC Classification)
- Unifocal disease
- Candidate for breast-conserving surgery
- Recommended treatment by multidisciplinary team
You will not qualify if you...
- Clinical stage T3-4, N1-3, M1
- Multifocal disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
John Wayne Cancer Institute, Providence Saint John's Health Center
Santa Monica, California, United States, 90404
Actively Recruiting
Research Team
J
Janie Grumley, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here